EUVIMED · CrossrefZeitschrift
International Journal of Pharmacokinetics
ISSN 2053-0846 · Informa UK Limited
Neueste Artikel
Intersex and Interspecies Pharmacokinetics of Metoprolol After Oral and Intravenous Dose Administration in Rats and Mice
PK–PD Interaction Study of Angiotensin II Antagonist, Losartan, with Selective Estrogen Receptor Modulator, Centchroman
Pharmacokinetic Considerations when Prescribing in Children
Pharmacokinetics of Intravenous and Oral Metformin and R,S-Verapamil in Sinclair, Hanford, Yucatan and Göttingen Minipigs
Enantioselective Disposition of Venlafaxine and its Metabolite O-Desmethylvenlafaxine in Rats
Method Development Challenges and Regulatory Expectation in Nifedipine
The Human Pharmacokinetics of Odanacatib, a Novel Cathepsin K Inhibitor, Predicted by Interspecies Scaling: a Retrospective Analysis
Let’s Abolish ‘Fold Higher’ and ‘Fold Increase’ from Our Lexicon
PK/PD Modeling of β-Blockers in Cardiovascular Disease: An Update
Practical Considerations When Designing and Conducting Clinical Pharmacokinetic Herb–Drug Interaction Studies
The Role of Pharmacometabonomics in Predicting Drug Pharmacokinetics
Pharmacokinetics Definitions in Regulatory Documents: Transfer from Small Molecules into Biologics
An Overview of Pharmacokinetic Considerations for the Use of Artemisinin-Based Combinations in Three Unique Populations
Toward Personalized Medicine with Physiologically Based Pharmacokinetic Modeling
Metabolism and Excretion of GCC-4401C, a Factor Xa Inhibitor, in Humans
Nanomedicine Literature: the Vicious Cycle of Reproducing the Irreproducible
What is the Role for Population Pharmacokinetics in Hemophilia?
Welcome to the International Journal of Pharmacokinetics
Pharmacokinetics of Next Generation Cyanide Antidote Sulfanegen in Rabbits
Clinical Pharmacokinetics of Methotrexate in Oncology
Clinical Food Effect Study in Early Drug Development: Timing Conundrum
Meeting the Rigorous Demands of Biosimilar Pharmacokinetics
European Regulatory Perspective on Pediatric Physiologically Based Pharmacokinetic Models
Effect of Food on Abiraterone Pharmacokinetics: A Review
Human Biliary Amount Prediction Using Simple, Bile Flow-Rate Corrected and Uridine Diphosphate Glucuronosyltransferase Activity Corrected Allometric Methods
Pharmacokinetics of a Novel Trioxane Antimalarial Drug 99/411: Alterations Upon Rifampicin Coadministration, Single and Multiple Oral Dose Drug–Drug Interactions in Sprague-Dawley Rats
Simple Methodology to Estimate Bioavailability in Early Clinical Studies: Theory and Reality
Intestinal Permeability and Role of P-Glycoprotein in Intestinal Absorption of Novel Triethylamine Containing Thiophene S006–830 Using Single-Pass Intestinal Perfusion in Rats
The Importance of Clinical Pharmacokinetic–Pharmacodynamic Studies in Unraveling the Determinants of Early and Late Tuberculosis Outcomes
Physiologically Based Pharmacokinetic Modeling to Understand the Observed Drug–Drug Interaction of LY2623091 with CYP3A Inhibitors Itraconazole and Diltiazem
EUVIMED